Drug Resistance Genes and Molecular Epidemiological Characteristics of Carbapenem-Resistant Klebsiella pneumonia
Yiqun Liao,Junjie Gong,Xiaoliang Yuan,Hongfei Lu,Lixia Jiang
DOI: https://doi.org/10.2147/IDR.S399142
2023-03-16
Infection and Drug Resistance
Abstract:Yiqun Liao, 1 Junjie Gong, 1 Xiaoliang Yuan, 2 Hongfei Lu, 1 Lixia Jiang 1 1 Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzhou, People's Republic of China; 2 Department of Respiratory Medicine, First Affiliated Hospital of Gannan Medical University, Ganzho, People's Republic of China Correspondence: Yiqun Liao, Department of Laboratory Medicine, First Affiliated Hospital of Gannan Medical University, 23 Qingnian Road, Zhanggong District, Ganzhou, 341000, Jiangxi Province, People's Republic of China, Tel +86-15979704263, Email Background: The global prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) has become a serious challenge for nosocomial infection and attracted worldwide attention. This study explored the drug resistance genes and molecular characteristics for CRKP, providing a reference for nosocomial prevention and control. Methods: A total of 42 CRKP isolates were collected from the First Affiliated Hospital of Gannan Medical University (Ganzhou, China) from January 2018 to February 2021. The drug resistance of CRKP was tested by the VitekII Compact system. Drug resistance gene expression was detected by poly-merase chain reaction (PCR), and molecular typing was performed by pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST). Results: All the 42 CRKP isolates were multi-drug resistant. Among them, 35 isolates (83.3%) produced bla KPC-2 and 12 isolates (28.6%) produced bla NDM-1 . The detection rate of bla IMP-4 and bla OXA-48 was 2.4% (1/42), respectively. Twelve isolates (28.6%) carried both bla KPC-2 and bla NDM-1 , one isolate (2.4%) carried both bla KPC-2 and bla IMP-4 , and one isolate (2.4%) carried bla KPC-2 , bla NDM-1 and bla OXA-48 . A variety of other extended-spectrum beta-lactamases (ESBLs) were also detected. All 42 isolates carried bla SHV and bla CTX-M-1 , 27 isolates (64.3%) carried bla TEM and 12 isolates (28.6%) carried bla CTX-M-9 . The MLST data classified the 42 CRKP isolates into 11 sequence types, mainly ST11, accounting for 61.9% (26/42), of which 92.3% of isolates (24/26) carrying bla KPC-2 . The PFGE results demonstrated that the 42 CRKP isolates could be divided into 20 clusters A-T, with cluster A (26.2%, 11/42) and cluster H (21.4%, 9/42) dominating, which were all ST11. Conclusion: The CRKP isolates were severely multi-drug resistant, and the main resistant gene was bla KPC-2 production, carrying multiple ESBLs genes simultaneously. The MLST and PFGE revealed that the ST11-bla KPC-2 Klebsiella pneumoniae was the main clonotype. Our findings may offer help to antibiotics selection and nosocomial infection prevention and control. Keywords: carbapenem-resistant Klebsiella pneumoniae , drug resistance genes, homology, molecular epidemiological characteristics Klebsiella pneumoniae ( K. pneumoniae ) is one of the most common gram-negative opportunistic pathogens, which can cause respiratory tract infection, urinary tract infection, bloodstream infection and abdominal infection. Carbapenems and other β-lactam antibiotics are normally thought to be a good choice for the treatment of multi-drug resistant gram-negative bacterial infections. But due to the large or unreasonable use of β-lactam antibiotics, extended-spectrum beta-lactamase (ESBLs) and carbapenemase emerge which are capable of hydrolysis of carbapenems. Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged subsequently and become a threat to public health, presenting rapid spread over global, 1 which can cause higher morbidity and mortality. 2,3 There were big differences with the resistance and prevalence of CRKP in different regions of China, 4 and the reports from Jiangxi China are limited, which brings great challenges to anti-infection treatment and nosocomial infection control. In our study, we analyzed the homology and the evolutionary relationship between isolates through genotyping and sequencing, and mastered the genome epidemiological characteristics of CRKP, so as to reveal the epidemic trend of CRKP and provide a basis for antibiotics selection, effectively reducing the nosocomial transmission of CRKP. CRKP isolates were those that were resistant to at least one of the carbapenems, including imipenem, meropenem and ertapenem. We collected 42 non-repetitive clinical isolates of CRKP from the First Affiliated Hospital of Gannan Medical University (Ganzhou, China) from January 2018 to February 2021, which all were confirmed by mat -Abstract Truncated-
pharmacology & pharmacy,infectious diseases